342 related articles for article (PubMed ID: 33301426)
1. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.
He X; Wan J; Yang X; Zhang X; Huang D; Li X; Zou Y; Chen C; Yu Z; Xie L; Zhang Y; Liu L; Li S; Zhao Y; Shao H; Yu Y; Zheng J
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33301426
[TBL] [Abstract][Full Text] [Related]
2. P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways.
He X; Xu Y; Huang D; Yu Z; Yu J; Xie L; Liu L; Yu Y; Chen C; Wan J; Zhang Y; Zheng J
Leukemia; 2023 Feb; 37(2):265-275. PubMed ID: 36418376
[TBL] [Abstract][Full Text] [Related]
3. Function of the P2X7 receptor in hematopoiesis and leukemogenesis.
He X; Zhang Y; Xu Y; Xie L; Yu Z; Zheng J
Exp Hematol; 2021 Dec; 104():40-47. PubMed ID: 34687808
[TBL] [Abstract][Full Text] [Related]
4. Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells.
Salvestrini V; Orecchioni S; Talarico G; Reggiani F; Mazzetti C; Bertolini F; Orioli E; Adinolfi E; Di Virgilio F; Pezzi A; Cavo M; Lemoli RM; Curti A
Oncotarget; 2017 Jan; 8(4):5895-5908. PubMed ID: 27980223
[TBL] [Abstract][Full Text] [Related]
5. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
[TBL] [Abstract][Full Text] [Related]
6. AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow.
Saito Y; Chapple RH; Lin A; Kitano A; Nakada D
Cell Stem Cell; 2015 Nov; 17(5):585-96. PubMed ID: 26440282
[TBL] [Abstract][Full Text] [Related]
7. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.
Griessinger E; Anjos-Afonso F; Pizzitola I; Rouault-Pierre K; Vargaftig J; Taussig D; Gribben J; Lassailly F; Bonnet D
Stem Cells Transl Med; 2014 Apr; 3(4):520-9. PubMed ID: 24493855
[TBL] [Abstract][Full Text] [Related]
8. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
Zhang Y; Xia F; Liu X; Yu Z; Xie L; Liu L; Chen C; Jiang H; Hao X; He X; Zhang F; Gu H; Zhu J; Bai H; Zhang CC; Chen GQ; Zheng J
J Clin Invest; 2018 May; 128(5):1737-1751. PubMed ID: 29584620
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche.
Hao X; Gu H; Chen C; Huang D; Zhao Y; Xie L; Zou Y; Shu HS; Zhang Y; He X; Lai X; Zhang X; Zhou BO; Zhang CC; Chen GQ; Yu Z; Yang Y; Zheng J
Cell Metab; 2019 Apr; 29(4):950-965.e6. PubMed ID: 30581117
[TBL] [Abstract][Full Text] [Related]
10. Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors.
Sun D; Junger WG; Yuan C; Zhang W; Bao Y; Qin D; Wang C; Tan L; Qi B; Zhu D; Zhang X; Yu T
Stem Cells; 2013 Jun; 31(6):1170-80. PubMed ID: 23404811
[TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
Front Immunol; 2021; 12():746492. PubMed ID: 34737747
[TBL] [Abstract][Full Text] [Related]
12. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
13. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.
Heuser M; Sly LM; Argiropoulos B; Kuchenbauer F; Lai C; Weng A; Leung M; Lin G; Brookes C; Fung S; Valk PJ; Delwel R; Löwenberg B; Krystal G; Humphries RK
Blood; 2009 Nov; 114(19):3983-93. PubMed ID: 19667399
[TBL] [Abstract][Full Text] [Related]
14. The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia.
Pegoraro A; Adinolfi E
Purinergic Signal; 2021 Sep; 17(3):319-321. PubMed ID: 34075525
[No Abstract] [Full Text] [Related]
15. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
16. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia.
Sumitomo Y; Koya J; Nakazaki K; Kataoka K; Tsuruta-Kishino T; Morita K; Sato T; Kurokawa M
Blood; 2016 Sep; 128(12):1614-24. PubMed ID: 27480114
[TBL] [Abstract][Full Text] [Related]
17. Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.
Chapellier M; Peña-Martínez P; Ramakrishnan R; Eriksson M; Talkhoncheh MS; Orsmark-Pietras C; Lilljebjörn H; Högberg C; Hagström-Andersson A; Fioretos T; Larsson J; Järås M
Haematologica; 2019 Oct; 104(10):2006-2016. PubMed ID: 30819903
[TBL] [Abstract][Full Text] [Related]
18. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3.
Feng W; Yang X; Wang L; Wang R; Yang F; Wang H; Liu X; Ren Q; Zhang Y; Zhu X; Zheng G
Haematologica; 2021 May; 106(5):1278-1289. PubMed ID: 32165482
[TBL] [Abstract][Full Text] [Related]
19. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
Zhou B; Jin X; Jin W; Huang X; Wu Y; Li H; Zhu W; Qin X; Ye H; Gao S
J Transl Med; 2020 Jun; 18(1):254. PubMed ID: 32580769
[TBL] [Abstract][Full Text] [Related]
20. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells.
Chen C; Lai X; Zhang Y; Xie L; Yu Z; Dan S; Jiang Y; Chen W; Liu L; Yang Y; Huang D; Zhao Y; Zheng J
Cell Rep; 2022 Apr; 39(1):110607. PubMed ID: 35385727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
